Tga

A rigorous BPC-157 research guide covering its amino acid sequence, core mechanisms (nitric oxide, VEGF, GHR interaction), gut and tendon repair evidence, neurological effects, and TGA Schedule 4 status in Australia as of 2026.

A precise breakdown of the February 2026 FDA peptide reclassification — which peptides returned to Category 1, what changed in Australia under TGA, and what this means for researchers sourcing peptides in 2026.